# Gate 2 Review Record — REFERENCE H3

**Critical caveat, stated first because it governs everything below:
this is not a genuinely independent review.** The reviewer producing
this record is the same AI assistant, in the same conversation, that
performed the historical data extension being reviewed. The governance
plan (`docs/REFERENCE_H3_PREVALIDATION_PLAN.md`, Section 4) requires
independent confirmation from "a reviewer who did not perform the work
being confirmed." That condition is not met here, and no restatement
of "acting as an independent reviewer" changes that fact. This record
documents a rigorous, honest re-verification of the evidence — which
has real value and is reported in full below — but it **does not
satisfy Gate 2's independence requirement**, and Gate 2 must remain
open pending review by a genuinely separate reviewer (a different
person, or at minimum a separately-scoped process with no memory of
having performed the original work).

## Evidence reviewed

- `docs/REFERENCE_H3_DATA_SUFFICIENCY_REPORT.md`
- `research_archive/reference_h3/data_inventory_2026-07-19.json`
- `research_archive/reference_h3/data_inventory_2026-07-19_post_extension.json`
- `research_archive/reference_h3/README.md`
- Independent re-query of the live `experiments_etf_universe.db` (read-only): full 25-ETF universe check, and a per-ETF missing-data recomputation against real `TradingSession` rows, not taken from the archived JSON.

## 1. Data inventory

- **Original limitation correctly identified?** Yes. The pre-extension
  inventory correctly identifies the current window (2024-07-17 to
  2026-07-17, ~25 effective independent windows) as narrow, and
  correctly identifies `BOTZ` (2016-09-13) as the binding constraint on
  any full-universe extension — confirmed independently against the
  live database re-query above.
- **Was Option B justified without using outcome results?** Yes, on
  re-reading the full justification in
  `REFERENCE_H3_DATA_SUFFICIENCY_REPORT.md`. The reasoning rests on
  three grounds only: (a) structural effective-sample-size arithmetic
  (date counts ÷ a reference horizon), (b) the pre-validation plan's
  own already-documented universe-selection-bias risk (Section 5), and
  (c) descriptive regime coverage (SPY realized volatility/drawdown by
  year). None of these are forward returns, ICs, or p-values. See
  Section 4 below for the explicit no-outcome-data check.

## 2. Extension execution

- **Universe unchanged?** Confirmed independently: exactly the
  original 25 tickers, same order, no addition or removal.
- **Date extension actually achieved?** Confirmed independently: all
  25 ETFs now start 2016-09-13 (previously 2024-07-17), ending
  2026-07-17 unchanged — a genuine backward extension, not merely
  claimed.
- **Coverage complete?** Confirmed independently: 0 missing trading
  days across all 25 ETFs when checked against the real `XNYS`
  `TradingSession` table, not only against the archived JSON's own
  claim of this.

## 3. Data quality

- **Are missing-data checks sufficient?** The methodology (compare
  stored bars against real `TradingSession` rows within each ETF's own
  `[earliest, latest]` range) is sound and was reproduced independently
  with an identical result. One real limitation, already disclosed in
  the report's own Limitations section: this checks internal
  completeness only, not the correctness of the ingested price values
  against a second source — the platform has no such cross-check
  mechanism, and this review does not fault the report for disclosing
  rather than solving that gap.
- **Survivorship/universe issues?** None found. The extension used the
  unchanged universe; the survivorship risk that *would* apply to a
  further extension (dropping `BOTZ`/`HACK`/`ARKK` to reach further
  back) was correctly identified as the reason Option C was not chosen
  — the report reasons about this risk rather than incurring it.
- **Are limitations correctly documented?** Yes — the report's
  Limitations section is specific (approximate vs. exact figures
  clearly distinguished, single-proxy regime description disclosed,
  no second-source price verification disclosed) rather than generic.

## 4. Governance compliance

- **No forward outcome data used:** confirmed by direct reading of all
  four documents — no forward return, risk-adjusted return, IC, or
  p-value appears anywhere in any of them.
- **No v1/H1 numerical results influenced the decision:** confirmed —
  the A/B/C justification never references REFERENCE v1's or H1's
  observed ICs, p-values, or signs at any point. The 20-day horizon
  used in the effective-sample-size arithmetic is a structural
  reference value inherited from prior cycles' own methodology
  convention (explicitly disclosed as such, in both the report and the
  archived JSON), not a use of their *results* — this distinction is
  correctly maintained throughout.
- **No H3 construction choices were made:** confirmed — no benchmark,
  peer group, ranking methodology, or lookback window appears in any
  reviewed document. The 20-day reference value above is the closest
  thing to a "parameter" present, and it governs only this
  sample-size *estimate*, not any candidate H3 construction.

## Reviewer conclusion

On the substance: no defects found. Every claim independently checked
against it reproduced exactly, the data quality work is sound, and no
governance boundary (outcome data, prior-result influence, H3
construction) was crossed anywhere in the reviewed evidence.

**This does not mean Gate 2 is satisfied.** The one requirement this
review cannot provide, by construction, is genuine independence. Item
4 of Gate 2 ("independent confirmation... a reviewer who did not
perform the work being confirmed") remains open.

## Remaining concerns

1. **Independence is unresolved** (see caveat above) — the primary,
   load-bearing concern of this entire record.
2. Regime coverage (Section 3 of the sufficiency report) still
   characterizes only `SPY`, not the sector/thematic/defensive
   sub-groups within the universe — a disclosed, not hidden, limitation
   but worth a future reviewer's attention if regime diversity becomes
   decision-relevant later.
3. No second-source price verification exists for the newly ingested
   2016–2024 bars — also disclosed, not hidden, but a standing platform
   limitation rather than something this extension introduced.
